研究者
J-GLOBAL ID：201801000527753161
更新日: 2021年10月26日
大谷 咲子
Otani Sakiko
この研究者にコンタクトする
直接研究者へメールで問い合わせることができます。
研究分野 (1件)：
呼吸器内科学
論文 (31件)：
Satoshi Ikeda, Terufumi Kato, Takashi Ogura, Akimasa Sekine, Tsuneyuki Oda, Noriyuki Masuda, Satoshi Igawa, Ken Katono, Sakiko Otani, Kouzo Yamada, et al. Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016. BMC cancer. 2018. 18. 1. 241-241
Satoshi Igawa, Sakiko Otani, Yoshiro Nakahara, Shinichiro Ryuge, Yasuhiro Hiyoshi, Tomoya Fukui, Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Yuichi Sato, et al. Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancer. Investigational New Drugs. 2018. 36. 1. 45-52
Yoshiro Nakahara, Jiichiro Sasaki, Tomoya Fukui, Sakiko Otani, Satoshi Igawa, Kazushige Hayakawa, Noriyuki Masuda. The role of prophylactic cranial irradiation for patients with small-cell lung cancer. Japanese Journal of Clinical Oncology. 2018. 48. 1. 26-30
Hideyuki Niwa, Sakiko Otani, Norihiro Nakada, Jiichiro Sasaki, Hideo Saka, Noriyuki Masuda. Nab-paclitaxel plus carboplatin as an effective and safe chemotherapy regimen for pulmonary carcinosarcoma with interstitial lung disease: A case report. Respiratory Medicine Case Reports. 2018. 23. 131-135
Tomoya Fukui, Yuriko Okuma, Yoshiro Nakahara, Sakiko Otani, Satoshi Igawa, Masato Katagiri, Hisashi Mitsufuji, Masaru Kubota, Yasuhiro Hiyoshi, Mikiko Ishihara, et al. Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study. Clinical Lung Cancer. 2018
もっと見る
学歴 (1件)：
1998 - 2004 北里大学 医学部
経歴 (1件)：
2006/04 - 2018/03 北里大学医学部呼吸器内科学
※ J-GLOBALの研究者情報は、
researchmap
の登録情報に基づき表示しています。 登録・更新については、
こちら
をご覧ください。
前のページに戻る
TOP
BOTTOM
